MESA, AZ / ACCESS Newswire / September 29, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announces a new era of leadership and innovation under CEO Marshall Perkins, whose extraordinary personal journey is now fueling the company's mission to transform healthcare. In early 2025, Perkins faced a near-fatal battle with advanced bone cancer that destroyed multiple vertebrae and left him hospitalized for months. ...

Accessibility StatementSkip Navigation HAUPPAUGE, N.Y., Sept. 29, 2025 /PRNewswire/ -- Minicarm.com, a leading provider of imaging solutions for orthopedic and surgical practices, is proud to announce that it has secured an allocation of the Hologic Fluoroscan® Insightâ"¢ FD Mini C-Arm for resale in the United States. As Hologic transitions away from commercial activities related to the Fluoroscan Insight product line, Minicarm.com will continue to offer sales support for the remaining inventory, ensuring ...

齐鲁晚报齐鲁壹点记者李培乐 9月26日—28日，首届医学人工智能大会在济南召开。此次大会以"AI赋能共筑卫生健康新生态"为主题，聚焦卫生健康行业"人工智能+"创新应用，吸引了 卫生健康、信息技术和人工智能领域的众多知名专家学者、领军人才齐聚一堂，共同探索人工智能在卫生健康各业务场景的落地路径与实践成果。 值得一提的是，在此次大会的东道主医学AI论坛上，国家健康医疗大数据中心(北方)发布了重要成果——北方中心数据要素基础设施及北方中心医学AI产 品暨高质量数据集建设试点方案。这一方案的发布，标志着在数据要素基础设施建设以及医学AI产品研发方面迈出了重要一步，将为卫生健康行业提供 更加精准、高效的数据支持和产品服务，推动行业向智能化、精准化方向迈进。 依托片区内国家健康医疗大数据中心(北方)这一核心平台，医学中心充分发挥其数据资源丰富、技术实力雄厚的优势，大力推动健康医疗数据的整合汇 聚、开放共享和创新应用，带动健康医疗大数据产业集聚发展，在脑机接口、AI辅助诊断、智能医疗、AI新药研发等领域，引领一批批具有创新能力和 技术优势的先进企业在此汇聚，形成了产业发展的良好生态。这些企业不仅带来了先进的技术和产品，更为 ...

Key Takeaways HTFL gained FDA clearance for its Next Gen Plaque Analysis platform.HTFL will see nationwide Cigna coverage for the platform starting in October.HTFL's upgrade improves plaque detection by 21% with 3D visualization.Heartflow (HTFL) has secured a dual milestone with FDA 510(k) clearance for its Next Gen Plaque Analysis platform and new nationwide coverage from Cigna, effective October. The update enhances detection accuracy by 21% compared to the prior version and offers 3D visualization of pla ...

We came across a bullish thesis on Masimo Corporation on HatedMoats’s Substack. In this article, we will summarize the bulls’ thesis on MASI. Masimo Corporation's share was trading at $142.13 as of September 22nd. MASI’s trailing P/E were 75.96 according to Yahoo Finance. 5 Highest Paying Countries for Neurosurgeons sfam_photo/Shutterstock.com Masimo Corporation (MASI) is a leading player in medical technology, best known for its Signal Extraction Technology (SET®) pulse oximetry platform, which has bec ...

Johnson & Johnson has increased its dividend every year for 63 consecutive years. It doesn't want to stop.Some stocks simply pay a regular dividend. The smarter ones also raise their dividend payout every year, putting more cash in their shareholders' pockets. The ultimate ones have been raising their dividends for several decades and are committed to continuing. Johnson & Johnson (JNJ 1.12%) falls in the third bracket.Johnson & Johnson, or J&J, is a Dividend King. That's an elite group of publicly listed c ...

Philips recently showcased its latest innovations in radiation therapy at the ASTRO 2025 Annual Meeting. The company introduced the Philips Rembra RT and Philips Areta RT CT platforms, which aim to enhance precision in cancer care. These advancements are designed to improve accuracy and efficiency in radiation therapy, addressing the increasing complexities of treatment planning. Citigroup maintains a Neutral rating for Philips (NYSE:PHG), with a raised price target, indicating cautious optimism. Philips in ...

公司股价表现 - Innovation Beverage Group Limited股价上涨312%至2.37美元 因饮料行业战略扩张及与BlockFuel Energy Inc合并计划[2][7] - bioAffinity Technologies Inc股价上涨265%至0.28美元 源于CyPath® Lung产品三项新临床研究证实其早期肺癌检测价值[3][7] - MEDIROM Healthcare Technologies Inc股价上涨116%至3.13美元 因日本陆上自卫队采用其REMONY健康监测系统[4][7] - Applied Therapeutics Inc股价上涨71%至0.95美元 基于 galactosemia治疗药物AT-007临床试验进展及CMT-SORD项目推进[5] 行业动态与催化剂 - 饮料行业出现能源跨界整合趋势 Innovation Beverage拟与结合油气勘探与比特币矿场供电的BlockFuel Energy合并[2] - 医疗检测行业技术突破 bioAffinity的CyPath® Lung产品可减少不必要的侵入性手术 提升早期肺癌诊断效率[3] - 数字健康监测系统获军方采用 MEDIROM的MOTHER Bracelet®技术被日本自卫队部署用于健康管理[4] - 生物制药行业监管进展 Applied Therapeutics将就govorestat药物治疗CMT-SORD适应症与FDA举行会议[5] 市场反应特征 - 多家公司因业务进展出现三位数百分比股价涨幅 反映市场对行业创新及临床进展的高度敏感性[1][6] - 投资者重点关注企业并购、临床数据发布、政府机构采购等关键催化剂事件[6]

The US Department of Commerce has opened an investigation to assess the national security implications regarding the importation of medical devices and other healthcare equipment, prompting a dip in medtech stock prices on 25 September. Trump’s Section 232 investigations have looked at national security implications across a plethora of goods, including steel, automobiles, and pharmaceutical products. Tariffs have largely been the outcome of such reviews this year. Salient for those in the medical device ...

MESA, ARIZONA / ACCESS Newswire / September 26, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) unveiled its AI Facial Health Risk Estimator for early detection of diabetic retinopathy, a leading cause of preventable blindness worldwide. The system analyzes subtle retinal cues captured from standard facial imaging, identifying microaneurysms, hemorrhages, and vascular leakage, allowing for non-invasive, accessible early screening. ...